-
Posted by
Two Blokes Tue at 12:00 AM -
Filed in
Stock
-
2 views
Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.27 per share a year ago.
